Phar­ma com­pa­nies tone down ESG men­tions, but not am­bi­tions

Phar­ma com­pa­nies are scal­ing back the use of terms like “ESG” and “di­ver­si­ty, eq­ui­ty and in­clu­sion,” much like com­pa­nies in oth­er in­dus­tries.

In phar­ma 10 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER